
Please try another search
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom and European Union. The company offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert. It also develops Podler, a portable blood culture unit for incubating and detecting growth in blood bottles. The company serves physicians, hospitals, laboratories, healthcare payers, and the medical profession. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Erika Kjellberg Eriksson | 60 | - | Director |
Erika kjellberg Eriksson | 60 | 2012 | Independent Chairperson |
Erika Kjellberg Eriksson | 63 | 2012 | Director |
Jonas Jarvius | 54 | 2008 | Independent Director |
Finn Sander Albrechtsen | 58 | 2023 | Independent Director |
Johan Bygge | 69 | 2025 | Chairman of the Board |
Mario Gualano | 56 | 2020 | Independent Deputy Chairperson |
Karin Fischer | 49 | 2023 | Independent Director |
Sebastian Backlund | 35 | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review